Short communication: Vizilite®- A Non-Invasive Oral Cancer Screening Tool Using Chemiluminescent Technology; Does it's Use Make Sense?

Dr. Nanda Kishore  Ghoshal

doi:10.46966/msjar.v5i2.200

Short communication: Vizilite®- A Non-Invasive Oral Cancer Screening Tool Using Chemiluminescent Technology; Does it's Use Make Sense?

Authors

Dr. Nanda Kishore Ghoshal MDS, Consultant Prosthodontist and Assistant Professor, Dept. of Dental Technique and Hygiene, Kalyani University, India.

DOI:

https://doi.org/10.46966/msjar.v5i2.200

Keywords:

Vizilite®, Chemiluminescence, Screening Method, and Oral cancer.

Abstract

Background: Early detection of oral cancer is crucial in improving survival rates. To improve early detection, the use of a dilute acetic acid rinse and observation under a ViziLite or chemiluminescent light (ViziLite; Zila Pharmaceuticals, Phoenix, AZ) has been recommended. Several screening techniques based on light interaction with tissue have been described to aid clinicians in the detection of early oral cancerous lesions. One of the most studied techniques is chemiluminescence. This method has been used in different studies but always by Oral Medicine specialists. Conclusion: Vizilite is a non-invasive screening technology widely used and best suited for clinicians with experiences, training and proven real time results, It is one of the modern device for oral cancer screening and consciousness, which has definite diagnostic value but limitations should be overcome by more confirmatory, sensitive, and specific tests.

Downloads

Published

2024-06-30

How to Cite

Ghoshal, D. N. K. . (2024). Short communication: Vizilite®- A Non-Invasive Oral Cancer Screening Tool Using Chemiluminescent Technology; Does it’s Use Make Sense?. Medical Science Journal for Advance Research, 5(2). https://doi.org/10.46966/msjar.v5i2.200

Download Citation

Issue

Vol. 5 No. 2 (2024): June, Medical Science Journal for Advance Research

Section

Short Communication

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:

They are authorized by their co-authors to enter into these arrangements.
The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
That it is not under consideration for publication elsewhere,
The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
They agree to the following license and copyright agreement.

License and Copyright Agreement

Authors who publish with Medical Science Journal for Advance Research agree to the following terms:

Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.